Oncology
From the Journals
Many ED visits may be preventable for NSCLC patients
Overall, 24% of ED visits were deemed preventable, and 10% were considered unnecessary.
Feature
COVID-19 vaccines: Safe for immunocompromised patients?
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
Conference Coverage
What to do when anticoagulation fails cancer patients
Conference Coverage
VTEs tied to immune checkpoint inhibitor cancer treatment
Retrospective analysis hints that cancer patients have an elevated risk for venous thromboembolism following treatment with an immune checkpoint...
Conference Coverage
Novel calculator predicts cancer risk in patients with CVD
Individual lifetime total cancer risk ranges from 1% to 52%.
Conference Coverage
Higher death rate seen in cancer patients with nosocomial COVID-19
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
From the Journals
American Cancer Society update: ‘It is best not to drink alcohol’
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
Opinion
Summary of the IDSA guidelines on the diagnosis of COVID-19
Learn about those recommendations that are most relevant to primary care clinicians.
Latest News
COVID-19 will likely change docs’ incentive targets, bonuses: Survey
Productivity benchmarks for physicians are likely to be lowered in light of plunging patient numbers from COVID-19, and bonuses are expected to...
From the Journals
Androgens may explain male vulnerability to COVID-19